Ernexa Therapeutics Inc. Cost of Goods Sold, Depreciation and Amortization (Deprecated 2018-01-31)
Ernexa Therapeutics Inc. (ERNA) reported Cost of Goods Sold, Depreciation and Amortization (Deprecated 2018-01-31) of $553.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-11.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSoldDepreciationAndAmortization · last filed 2018-05-11
- Ernexa Therapeutics Inc. cost of goods sold, depreciation and amortization (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $553.00K, a 12.63% increase year-over-year.
- Ernexa Therapeutics Inc. cost of goods sold, depreciation and amortization (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $517.00K, a 13.98% decline year-over-year.
- Ernexa Therapeutics Inc. cost of goods sold, depreciation and amortization (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $509.00K, a 15.31% decline year-over-year.
- Ernexa Therapeutics Inc. cost of goods sold, depreciation and amortization (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $465.00K, a 25.00% decline year-over-year.
- Ernexa Therapeutics Inc. cost of goods sold, depreciation and amortization (deprecated 2018-01-31) for fiscal 2017 was $1.98M, a 19.55% decline from fiscal 2016.
- Ernexa Therapeutics Inc. cost of goods sold, depreciation and amortization (deprecated 2018-01-31) for fiscal 2016 was $2.46M, a 5.74% decline from fiscal 2015.
- Ernexa Therapeutics Inc. cost of goods sold, depreciation and amortization (deprecated 2018-01-31) for fiscal 2015 was $2.62M, a 22.25% increase from fiscal 2014.
- Ernexa Therapeutics Inc. cost of goods sold, depreciation and amortization (deprecated 2018-01-31) for fiscal 2014 was $2.14M, a 1.09% increase from fiscal 2013.
| Period end | Cost of Goods Sold, Depreciation and Amortization (Deprecated 2018-01-31) 3 month | Cost of Goods Sold, Depreciation and Amortization (Deprecated 2018-01-31) 6 month | Cost of Goods Sold, Depreciation and Amortization (Deprecated 2018-01-31) 9 month | Cost of Goods Sold, Depreciation and Amortization (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $553.00K 10-Q · filed 2018-05-11 | $1.07M derived: sum of 2 quarters · filed 2018-05-11 | $1.58M derived: sum of 3 quarters · filed 2018-05-11 | $2.04M derived: sum of 4 quarters · filed 2018-05-11 |
| 2017-12-31 | $517.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $1.03M derived: sum of 2 quarters · filed 2018-03-09 | $1.49M derived: sum of 3 quarters · filed 2018-03-09 | $1.98M 10-K · filed 2018-03-09 |
| 2017-09-30 | $509.00K 10-Q · filed 2017-11-08 | $974.00K derived: sum of 2 quarters · filed 2017-11-08 | $1.47M 10-Q · filed 2017-11-08 | $2.07M derived: sum of 4 quarters · filed 2018-05-11 |
| 2017-06-30 | $465.00K 10-Q · filed 2017-08-04 | $956.00K 10-Q · filed 2017-08-04 | $1.56M derived: sum of 3 quarters · filed 2018-05-11 | $2.16M derived: sum of 4 quarters · filed 2018-05-11 |
| 2017-03-31 | $491.00K 10-Q · filed 2018-05-11 | $1.09M derived: sum of 2 quarters · filed 2018-05-11 | $1.69M derived: sum of 3 quarters · filed 2018-05-11 | $2.31M derived: sum of 4 quarters · filed 2018-05-11 |
| 2016-12-31 | $601.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $1.20M derived: sum of 2 quarters · filed 2018-03-09 | $1.82M derived: sum of 3 quarters · filed 2018-03-09 | $2.46M 10-K · filed 2018-03-09 |
| 2016-09-30 | $601.00K 10-Q · filed 2017-11-08 | $1.22M derived: sum of 2 quarters · filed 2017-11-08 | $1.86M 10-Q · filed 2017-11-08 | $2.67M derived: sum of 4 quarters · filed 2017-11-08 |
| 2016-06-30 | $620.00K 10-Q · filed 2017-08-04 | $1.26M 10-Q · filed 2017-08-04 | $2.07M derived: sum of 3 quarters · filed 2017-08-04 | $2.70M derived: sum of 4 quarters · filed 2017-08-04 |
| 2016-03-31 | $643.00K 10-Q · filed 2017-05-04 | $1.45M derived: sum of 2 quarters · filed 2017-05-04 | $2.08M derived: sum of 3 quarters · filed 2017-05-04 | $2.68M derived: sum of 4 quarters · filed 2017-05-04 |
| 2015-12-31 | $808.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $1.44M derived: sum of 2 quarters · filed 2017-03-09 | $2.04M derived: sum of 3 quarters · filed 2017-03-09 | $2.62M 10-K · filed 2017-03-09 |
| 2015-09-30 | $630.00K 10-Q · filed 2016-11-09 | $1.23M derived: sum of 2 quarters · filed 2016-11-09 | $1.81M 10-Q · filed 2016-11-09 | $2.33M derived: sum of 4 quarters · filed 2016-11-09 |
| 2015-06-30 | $597.00K 10-Q · filed 2016-08-04 | $1.18M 10-Q · filed 2016-08-04 | $1.70M derived: sum of 3 quarters · filed 2016-08-04 | $2.24M derived: sum of 4 quarters · filed 2016-08-04 |
| 2015-03-31 | $580.00K 10-Q · filed 2016-05-09 | $1.10M derived: sum of 2 quarters · filed 2016-05-09 | $1.65M derived: sum of 3 quarters · filed 2016-05-09 | $2.19M derived: sum of 4 quarters · filed 2016-05-09 |
| 2014-12-31 | $523.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $1.07M derived: sum of 2 quarters · filed 2016-03-15 | $1.61M derived: sum of 3 quarters · filed 2016-03-15 | $2.14M 10-K · filed 2016-03-15 |
| 2014-09-30 | $544.00K 10-Q · filed 2015-11-09 | $1.08M derived: sum of 2 quarters · filed 2015-11-09 | $1.62M 10-Q · filed 2015-11-09 | $2.13M derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-06-30 | $539.00K 10-Q · filed 2015-08-10 | $1.07M 10-Q · filed 2015-08-10 | $1.59M derived: sum of 3 quarters · filed 2015-08-10 | $2.08M derived: sum of 4 quarters · filed 2015-08-10 |
| 2014-03-31 | $533.00K 10-Q · filed 2015-05-08 | $1.05M derived: sum of 2 quarters · filed 2015-05-08 | $1.54M derived: sum of 3 quarters · filed 2015-05-08 | $2.06M derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | $517.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $1.01M derived: sum of 2 quarters · filed 2015-03-27 | $1.53M derived: sum of 3 quarters · filed 2015-03-27 | $2.12M 10-K · filed 2015-03-27 |
| 2013-09-30 | $495.00K 10-Q · filed 2014-11-07 | $1.01M derived: sum of 2 quarters · filed 2014-11-07 | $1.60M 10-Q · filed 2014-11-07 | $2.11M derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-06-30 | $514.00K 10-Q · filed 2014-08-14 | $1.10M 10-Q · filed 2014-08-14 | $1.61M derived: sum of 3 quarters · filed 2014-08-14 | $2.15M derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | $590.00K 10-Q · filed 2014-05-15 | $1.10M derived: sum of 2 quarters · filed 2014-05-15 | $1.64M derived: sum of 3 quarters · filed 2014-05-15 | $2.20M derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | $508.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $1.05M derived: sum of 2 quarters · filed 2014-03-31 | $1.61M derived: sum of 3 quarters · filed 2014-03-31 | $2.16M 10-K · filed 2014-03-31 |
| 2012-09-30 | $542.00K 10-Q · filed 2013-11-14 | $1.10M derived: sum of 2 quarters · filed 2013-11-14 | $1.65M 10-Q · filed 2013-11-14 | $2.21M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $559.00K 10-Q · filed 2013-08-14 | $1.11M 10-Q · filed 2013-08-14 | $1.67M derived: sum of 3 quarters · filed 2013-08-14 | $2.22M derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $549.00K 10-Q · filed 2013-05-13 | $1.11M derived: sum of 2 quarters · filed 2013-05-13 | $1.66M derived: sum of 3 quarters · filed 2013-05-13 | $2.27M derived: sum of 4 quarters · filed 2013-05-13 |
| 2011-12-31 | $560.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $1.11M derived: sum of 2 quarters · filed 2013-03-29 | $1.72M derived: sum of 3 quarters · filed 2013-03-29 | $2.37M 10-K · filed 2013-03-29 |
| 2011-09-30 | $550.00K 10-Q · filed 2012-11-09 | $1.16M derived: sum of 2 quarters · filed 2012-11-09 | $1.81M 10-Q · filed 2012-11-09 | $2.45M derived: sum of 4 quarters · filed 2012-11-09 |
| 2011-06-30 | $611.00K 10-Q · filed 2012-08-14 | $1.26M 10-Q · filed 2012-08-14 | $1.90M derived: sum of 3 quarters · filed 2012-08-14 | $2.54M derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $648.00K 10-Q · filed 2012-05-11 | $1.29M derived: sum of 2 quarters · filed 2012-05-11 | $1.93M derived: sum of 3 quarters · filed 2012-05-11 | $2.58M derived: sum of 4 quarters · filed 2012-05-11 |
| 2010-12-31 | $640.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $1.28M derived: sum of 2 quarters · filed 2012-03-30 | $1.93M derived: sum of 3 quarters · filed 2012-03-30 | $2.54M 10-K · filed 2012-03-30 |
| 2010-09-30 | $644.00K 10-Q · filed 2011-11-14 | $1.29M derived: sum of 2 quarters · filed 2011-11-14 | $1.90M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $646.00K 10-Q · filed 2011-08-12 | $1.25M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |